title: [Role of probiotics in Obstetrics and Gynecology].
abstract: The human microbiota is estimated to be 2.5-3.0 kg. Bacterial colonization starts during delivery, due to fetal contact with vaginal and intestinal maternal microorganisms. The oligosaccharides in human breast milk stimulate the growth of bacteria, which provide the optimal environment for intestinal mucosal immunity development. Additionally, breast milk has its own microbiota and it is altered in mastitis. The vagina is another important microenvironment. Vaginal dysbiosis leads to bacterial vaginosis and vaginal candidiasis, both of them very frequent in reproductive life. The probiotics are a potential and encouraging treatment for all microbiota alterations. Nevertheless, additional studies are required to confirm the benefits of probiotics.
authors: Hospital Clínico Universitario de Valencia.. anacastroperez1986@gmail.com.
authors: A
authors: A
authors: Castro
authors: Hospital Clínico Universitario de Valencia..
authors: M
authors: M
authors: González
authors: Departamento de Biología Funcional y Antropología Física, Facultad de Ciencias Biológicas, Universidad de Valencia..
authors: J J
authors: JJ
authors: Tarín
authors: Hospital Clínico Universitario de Valencia. Departamento de Pediatría, Obstetricia y Ginecología. Universidad de Valencia..
authors: A
authors: A
authors: Cano
mesh_terms: D005260:Female; D006176:Gynecology; D006801:Humans; D064307:Microbiota; D009774:Obstetrics; D019936:Probiotics / Q000627:therapeutic use*; D014621:Vagina / Q000382:microbiology; D016585:Vaginosis, Bacterial / Q000382:microbiology / Q000628:therapy